MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV), an advanced medical technologies company, today announced financial results for its third quarter ended June 30, 2016.
Revenue for the three months ended June 30, 2016 was $2,600,002, operating expenses were $1,793,108 and net loss was $156,793 or $0.02 per share. For the nine months ended June 30, 2016, revenue was $5,838,384, operating expenses were $4594,223 and net loss was $956,087 or $0.07 per share.
Revenue for the three months ended June 30, 2016 was $2,600,002, operating expenses were $1,793,108 and net loss was $156,793 or $0.02 per share. For the nine months ended June 30, 2016, revenue was $5,838,384, operating expenses were $4594,223 and net loss was $956,087 or $0.07 per share.
